Selected research
Industry Research
Ethinyl Estradiol and Levonorgestrel Industry Research Report 2026
Market perspective
The global Ethinyl Estradiol and Levonorgestrel market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ethinyl Estradiol and Levonorgestrel is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ethinyl Estradiol and Levonorgestrel is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ethinyl Estradiol and Levonorgestrel is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ethinyl Estradiol and Levonorgestrel include Teva, Mylan, Pfizer, Novast, Mayne Pharma, LUPIN, Laboratorios Leon Farma, Glenmark and Avion Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ethinyl Estradiol and Levonorgestrel market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ethinyl Estradiol and Levonorgestrel Market by Company
Teva
Mylan
Pfizer
Novast
Mayne Pharma
LUPIN
Laboratorios Leon Farma
Glenmark
Avion Pharmaceuticals
Aurobindo Pharma
Amneal Pharmaceuticals
Allergan
Ethinyl Estradiol and Levonorgestrel Segment by Type
0.01mg/0.15mg
0.02mg/0.09mg
0.02mg/0.1mg
0.03mg/0.15mg
Ethinyl Estradiol and Levonorgestrel Segment by Application
Hospital
Drug Store
Ethinyl Estradiol and Levonorgestrel Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ethinyl Estradiol and Levonorgestrel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ethinyl Estradiol and Levonorgestrel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ethinyl Estradiol and Levonorgestrel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ethinyl Estradiol and Levonorgestrel manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ethinyl Estradiol and Levonorgestrel by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ethinyl Estradiol and Levonorgestrel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.01mg/0.15mg
- 0.02mg/0.09mg
- 0.02mg/0.1mg
- 0.03mg/0.15mg
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Mylan
- Pfizer
- Novast
- Mayne Pharma
- LUPIN
- Laboratorios Leon Farma
- Glenmark
- Avion Pharmaceuticals
- Aurobindo Pharma
- Amneal Pharmaceuticals
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ethinyl Estradiol and Levonorgestrel Market Size (2021-2032)
- 2.2.2 Global Ethinyl Estradiol and Levonorgestrel Sales (2021-2032)
- 2.2.3 Global Ethinyl Estradiol and Levonorgestrel Market Average Price (2021-2032)
- 2.3 Ethinyl Estradiol and Levonorgestrel by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.01mg/0.15mg
- 2.3.3 0.02mg/0.09mg
- 2.3.4 0.02mg/0.1mg
- 2.3.5 0.03mg/0.15mg
- 2.4 Ethinyl Estradiol and Levonorgestrel by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ethinyl Estradiol and Levonorgestrel Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ethinyl Estradiol and Levonorgestrel Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Ethinyl Estradiol and Levonorgestrel Revenue of Manufacturers (2021-2026)
- 3.4 Global Ethinyl Estradiol and Levonorgestrel Average Price by Manufacturers (2021-2026)
- 3.5 Global Ethinyl Estradiol and Levonorgestrel Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ethinyl Estradiol and Levonorgestrel, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ethinyl Estradiol and Levonorgestrel, Product Type & Application
- 3.8 Global Manufacturers of Ethinyl Estradiol and Levonorgestrel, Established Date
- 3.9 Global Ethinyl Estradiol and Levonorgestrel Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Novast
- 4.4.1 Novast Company Information
- 4.4.2 Novast Business Overview
- 4.4.3 Novast Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novast Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.4.5 Novast Recent Developments
- 4.5 Mayne Pharma
- 4.5.1 Mayne Pharma Company Information
- 4.5.2 Mayne Pharma Business Overview
- 4.5.3 Mayne Pharma Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mayne Pharma Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.5.5 Mayne Pharma Recent Developments
- 4.6 LUPIN
- 4.6.1 LUPIN Company Information
- 4.6.2 LUPIN Business Overview
- 4.6.3 LUPIN Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LUPIN Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.6.5 LUPIN Recent Developments
- 4.7 Laboratorios Leon Farma
- 4.7.1 Laboratorios Leon Farma Company Information
- 4.7.2 Laboratorios Leon Farma Business Overview
- 4.7.3 Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.7.5 Laboratorios Leon Farma Recent Developments
- 4.8 Glenmark
- 4.8.1 Glenmark Company Information
- 4.8.2 Glenmark Business Overview
- 4.8.3 Glenmark Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Glenmark Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.8.5 Glenmark Recent Developments
- 4.9 Avion Pharmaceuticals
- 4.9.1 Avion Pharmaceuticals Company Information
- 4.9.2 Avion Pharmaceuticals Business Overview
- 4.9.3 Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.9.5 Avion Pharmaceuticals Recent Developments
- 4.10 Aurobindo Pharma
- 4.10.1 Aurobindo Pharma Company Information
- 4.10.2 Aurobindo Pharma Business Overview
- 4.10.3 Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.10.5 Aurobindo Pharma Recent Developments
- 4.11 Amneal Pharmaceuticals
- 4.11.1 Amneal Pharmaceuticals Company Information
- 4.11.2 Amneal Pharmaceuticals Business Overview
- 4.11.3 Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.11.5 Amneal Pharmaceuticals Recent Developments
- 4.12 Allergan
- 4.12.1 Allergan Company Information
- 4.12.2 Allergan Business Overview
- 4.12.3 Allergan Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Allergan Ethinyl Estradiol and Levonorgestrel Product Portfolio
- 4.12.5 Allergan Recent Developments
5 Global Ethinyl Estradiol and Levonorgestrel Market Scenario by Region
- 5.1 Global Ethinyl Estradiol and Levonorgestrel Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ethinyl Estradiol and Levonorgestrel Sales by Region: 2021-2032
- 5.2.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Region: 2021-2026
- 5.2.2 Global Ethinyl Estradiol and Levonorgestrel Sales by Region: 2027-2032
- 5.3 Global Ethinyl Estradiol and Levonorgestrel Revenue by Region: 2021-2032
- 5.3.1 Global Ethinyl Estradiol and Levonorgestrel Revenue by Region: 2021-2026
- 5.3.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Region: 2027-2032
- 5.4 North America Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
- 5.4.1 North America Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ethinyl Estradiol and Levonorgestrel Sales by Country (2021-2032)
- 5.4.3 North America Ethinyl Estradiol and Levonorgestrel Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
- 5.5.1 Europe Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ethinyl Estradiol and Levonorgestrel Sales by Country (2021-2032)
- 5.5.3 Europe Ethinyl Estradiol and Levonorgestrel Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ethinyl Estradiol and Levonorgestrel Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ethinyl Estradiol and Levonorgestrel Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
- 5.7.1 South America Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ethinyl Estradiol and Levonorgestrel Sales by Country (2021-2032)
- 5.7.3 South America Ethinyl Estradiol and Levonorgestrel Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Type (2021-2032)
- 6.1.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Ethinyl Estradiol and Levonorgestrel Sales Market Share by Type (2021-2032)
- 6.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Type (2021-2032)
- 6.2.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ethinyl Estradiol and Levonorgestrel Revenue Market Share by Type (2021-2032)
- 6.3 Global Ethinyl Estradiol and Levonorgestrel Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Application (2021-2032)
- 7.1.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Ethinyl Estradiol and Levonorgestrel Sales Market Share by Application (2021-2032)
- 7.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Application (2021-2032)
- 7.2.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ethinyl Estradiol and Levonorgestrel Revenue Market Share by Application (2021-2032)
- 7.3 Global Ethinyl Estradiol and Levonorgestrel Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ethinyl Estradiol and Levonorgestrel Value Chain Analysis
- 8.1.1 Ethinyl Estradiol and Levonorgestrel Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ethinyl Estradiol and Levonorgestrel Production Mode & Process
- 8.2 Ethinyl Estradiol and Levonorgestrel Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ethinyl Estradiol and Levonorgestrel Distributors
- 8.2.3 Ethinyl Estradiol and Levonorgestrel Customers
9 Global Ethinyl Estradiol and Levonorgestrel Analyzing Market Dynamics
- 9.1 Ethinyl Estradiol and Levonorgestrel Industry Trends
- 9.2 Ethinyl Estradiol and Levonorgestrel Industry Drivers
- 9.3 Ethinyl Estradiol and Levonorgestrel Industry Opportunities and Challenges
- 9.4 Ethinyl Estradiol and Levonorgestrel Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst